Merck
MRK
$83.48
Share price
-0.23%
Change (1 day)
-34.84%
Change (1 year)
Categories
EPS for Merck (MRK)
EPS in 2025 (TTM): $6.90
According to Merck's latest financial reports the company's current EPS (TTM) is $6.90. In 2024 the company made an earnings per share (EPS) of $6.76 an increase over its 2023 EPS that were of $0.15.
EPS history for Merck from 2011 to 2025
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2025 (TTM) | $6.90 | 2.04% |
| 2024 | $6.76 | 4308.46% |
| 2023 | $0.15 | -97.32% |
| 2022 | $5.73 | 10.92% |
| 2021 | $5.17 | 84.68% |
| 2020 | $2.80 | -27.2% |
| 2019 | $3.84 | 63.44% |
| 2018 | $2.35 | 151.11% |
| 2017 | $0.94 | -54.58% |
| 2016 | $2.06 | 30.21% |
| 2015 | $1.58 | -61.99% |
| 2014 | $4.16 | 180.51% |
| 2013 | $1.48 | -31.82% |
| 2012 | $2.18 | 6.62% |
| 2011 | $2.04 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | $1.39 | -79.85% | 🇺🇸 USA |
 Johnson & Johnson JNJ | $9.07 | 31.47% | 🇺🇸 USA |
 Eli Lilly LLY | $12.36 | 79.14% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $2.68 | -61.14% | 🇺🇸 USA |
 Sanofi SNY | $2.85 | -58.72% | 🇫🇷 France |
 GlaxoSmithKline GSK | $1.56 | -77.39% | 🇬🇧 UK |
 Teva Pharmaceutical Industries TEVA | -$1.14 | -116.53% | 🇮🇱 Israel |
 Novartis NVS | $6.43 | -6.78% | 🇨🇭 Switzerland |
 Abbott Laboratories ABT | $7.79 | 12.90% | 🇺🇸 USA |
 Amgen AMGN | $11.05 | 60.21% | 🇺🇸 USA |